30 Results for "

insulin-sensitizing

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "insulin-sensitizing" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-112584
CAS No.: 7150-23-4
Purity:  99.94%
Synonyms: 6-Methoxynicotinamide
Research Areas:  

Metabolic Disease

JBSNF-000088 (6-Methoxynicotinamide), a analog of nicotinamide (NA), is a potent and orally active Nicotinamide N-methyltransferase (NNMT) inhibitor with IC50s of 1.8 µM, 2.8 µM, and 5.0 µM for human NNMT, monkey NNMT and mouse NNMT, respectively. JBSNF-000088 inhibits NNMT activity, reduces MNA levels and drives insulin sensitization, glucose modulation and body weight reduction in animal models of metabolic disease .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13682
CAS No.: 83461-56-7
Purity:  ≥98.0%
Synonyms: MTP-PE; L-MTP-PE; CGP 19835
Research Areas:  

Inflammation/Immunology Cancer

Mifamurtide (MTP-PE), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide is a specific ligand for NOD2 and acts as an insulin sensitizer. Mifamurtide has potential for use in rare disease and osteosarcoma research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19960
CAS No.: 393514-24-4
BCTC is an orally active current inhibitor of vanilloid receptor type 1 (VR1). BCTC is a transient receptor potential cation channel subfamily M member 8 (TRPM8) and transient receptor potential vanilloid 1 (TRPV1) antagonist. BCTC is an insulin sensitizer and secretor. BCTC has anticancer and analgesic effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13682B
CAS No.: 90825-43-7
Purity:  98.19%
Synonyms: MTP-PE sodium; L-MTP-PE sodium; CGP 19835 sodium
Research Areas:  

Inflammation/Immunology Cancer

Mifamurtide sodium (MTP-PE sodium), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide sodium is a specific ligand for NOD2 and acts as an insulin sensitizer. Mifamurtide sodium has potential for use in rare disease and osteosarcoma research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13682C
Purity:  ≥98.0%
Synonyms: MTP-PE TFA; L-MTP-PE TFA; CGP 19835 TFA
Research Areas:  

Inflammation/Immunology Cancer

Mifamurtide TFA (MTP-PE TFA), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide TFA is a specific ligand for NOD2 and acts as an insulin sensitizer. Mifamurtide TFA has potential for use in rare disease and osteosarcoma research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100560
CAS No.: 21293-29-8
Purity:  99.64%
Synonyms: (S)​-​(+)​-​Abscisic acid; ABA
Abscisic acid ((S)-(+)-Abscisic acid), an orally active phytohormone in fruits and vegetables, is an endogenously produced mammalian hormone. Abscisic acid is a growth inhibitor and can regulate many aspects of plant growth and development. Abscisic acid inhibits proton pump (H +-ATPase) and leads to the plasma membrane depolarization in a Ca 2+-dependent manner. Abscisic acid, a LANCL2 natural ligand, is a potent insulin-sensitizing compound and has the potential for pre-diabetes, type 2 diabetes and metabolic syndrome .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100550
CAS No.: 146062-49-9
Purity:  98.55%
Synonyms: Mitoglitazone; CAY10415
MSDC 0160 (Mitoglitazone) is a mitochondrial target of thiazolidinediones (mTOT)-modulating insulin sensitizer and a modulator of mitochondrial pyruvate carrier (MPC). MSDC 0160 is a thiazolidinedione (TZD) with antidiabetic and neuroprotective activities. MSDC 0160 has the potential for Alzheimer′s disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108022A
CAS No.: 1314533-27-1
Purity:  99.53%
Synonyms: MSDC-0602K
Target:  

Insulin Receptor PPAR

Research Areas:  

Metabolic Disease

Azemiglitazone potassium (MSDC-0602K), a PPARγ-sparing thiazolidinedione (Ps-TZD), binds to PPARγ with the IC50 of 18.25 μM . Azemiglitazone potassium modulates the mitochondrial pyruvate carrier (MPC). Azemiglitazone potassium can be used for the research of fatty liver including dysfunctional lipid metabolism, inflammation, and insulin resistance . Azemiglitazone potassium, an insulin sensitizer, improves insulinemia and fatty liver disease in mice, alone and in combination with Liraglutide .
loading...
    loading...
Cat. No.: HY-101064
CAS No.: 35661-60-0
Purity:  99.89%
Synonyms: N-FMOC-leucine; NPC 15199; NSC 334290
Fmoc-Leucine (N-FMOC-leucine) is an anti-inflammatory agent that not only promotes extracellular Ca 2+ influx but also facilitates intracellular Ca 2+ release. Fmoc-Leucine is a selective ligand for PPARγ (Ki = 15 μM), exhibiting insulin-sensitizing effects but with weak fatogenic activity. Fmoc-Leucine exhibits unique self-assembly properties and can form transient gels, stable gels, or crystals/2D sheets through different pathways. Fmoc-Leucine can be used in the research of diabetes, colitis, and bladder cancer .
loading...
    loading...
Cat. No.: HY-118567
CAS No.: 38213-69-3
Purity:  99.34%
Synonyms: BMOV
Target:  

SHP2 Phosphatase

Research Areas:  

Metabolic Disease

Bis(maltolato)oxovanadium(IV) (BMOV) is a potent, reversible, competitive and orally active pan-PTP (protein tyrosine phosphatases) inhibitor. Bis(maltolato)oxovanadium(IV) inhibits HCPTPA, PTP1B, HPTPβ and SHP2 with IC50s of 126 nM, 109 nM, 26 nM and 201 nM, respectively. Bis(maltolato)oxovanadium(IV) is a potent insulin sensitizer .
loading...
    loading...
Cat. No.: HY-100560R
CAS No.: 21293-29-8
Synonyms: (S)​-​(+)​-​Abscisic acid (Standard); ABA (Standard)
Abscisic acid (Standard) is the analytical standard of Abscisic acid. This product is intended for research and analytical applications. Abscisic acid ((S)-(+)-Abscisic acid), an orally active phytohormone in fruits and vegetables, is an endogenously produced mammalian hormone. Abscisic acid is a growth inhibitor and can regulate many aspects of plant growth and development. Abscisic acid inhibits proton pump (H+-ATPase) and leads to the plasma membrane depolarization in a Ca2+-dependent manner. Abscisic acid, a LANCL2 natural ligand, is a potent insulin-sensitizing compound and has the potential for pre-diabetes, type 2 diabetes and metabolic syndrome .
loading...
    loading...
Cat. No.: HY-16421
CAS No.: 222834-30-2
Synonyms: (-)-DRF 2725; NNC 61-0029
Target:  

PPAR

Research Areas:  

Metabolic Disease

Ragaglitazar is a PPARα and PPARγ agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic.
loading...
    loading...
Cat. No.: HY-108523
CAS No.: 180713-37-5
Purity:  ≥99.0%
Synonyms: UVI 2112
Target:  

RAR/RXR

Research Areas:  

Metabolic Disease

LG100754 (UVI 2112) is a RXR dimers modulater. LG100754 acts as a RXR:RXR homodimer antagonist, but functions as a agonist towards RXR:PPARα and RXR:PPARγ heterodimers. LG100754 is an insulin sensitizer that functions through RXR .
loading...
    loading...
Cat. No.: HY-100560S
CAS No.: 721948-65-8
Purity:  98.69%
Synonyms: (S)​-​(+)​-​Abscisic acid-d6; ABA-d6
Abscisic acid-d6 is deuterium labeled Abscisic acid. Abscisic acid inhibits proton pump (H +-ATPase) .
loading...
    loading...
Cat. No.: HY-N2177
CAS No.: 29220-16-4
3-​Dehydrotrametenolic acid, isolated from the sclerotium of Poria cocos, is a lactate dehydrogenase (LDH) inhibitor. 3-​Dehydrotrametenolic acid promotes adipocyte differentiation in vitro and acts as an insulin sensitizer in vivo. 3-​Dehydrotrametenolic acid induces apoptosis and has anticancer activity .
loading...
    loading...
Cat. No.: HY-121900
CAS No.: 862901-87-9
Purity:  99.79%
Target:  

PPAR

Research Areas:  

Metabolic Disease Endocrinology

LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties .
loading...
    loading...
Cat. No.: HY-164368
CAS No.: 2761446-81-3
GLUT4 activator 2 (C59) is an insulin sensitizer, which can be used for research of diabetic diseases. GLUT4 activator 2 improves glucose uptake and insulin sensitivity in rodents. GLUT4 activator 2 interacts with Unc119 and Unc119B resulting in increased insulin sensitivity and GLUT4 translocation .
loading...
    loading...
Cat. No.: HY-178958
CAS No.: 3122526-69-3
PPAR agonist 7 is an orally active pan-PPAR agonist, demonstrating potent activation of all three subtypes, PPARα (EC50 = 1.51 μM), PPARδ (EC50 = 1.11 μM), and PPARγ (EC50 = 3.14 μM). PPAR agonist 7 significantly enhances glucose uptake in adipocytes while exhibiting minimal adipogenic activity. PPAR agonist 7 can suppress PPARγ Ser273 phosphorylation in white adipose tissue and upregulate insulin-sensitizing genes. PPAR agonist 7 does not cause weight gain or fluid retention in high-fat diet (HFD)/ Streptozotocin (HY-13753) (STZ)-induced type 2 diabetes mellitus (T2DM) models. PPAR agonist 7 has selective modulation of PPAR signaling pathways without activation of adipogenic gene programs. PPAR agonist 7 can be used for the study of diabetes .
loading...
    loading...
Cat. No.: HY-13682A
CAS No.: 838853-48-8
Synonyms: MTP-PE sodium hydrate; L-MTP-PE sodium hydrate; CGP 19835 sodium hydrate
Research Areas:  

Inflammation/Immunology Cancer

Mifamurtide (MTP-PE; CGP 19835) sodium hydrate is the sodium hydrate of mifamurtide. Mifamurtide is a nonspecific immunomodulator that acts by stimulating immune responses by activating macrophages and monocytes. Mifamurtide is a specific ligand for NOD2 and is used as an insulin sensitizer and may also be used in osteosarcoma research .
loading...
    loading...
Cat. No.: HY-19176
CAS No.: 159978-02-6
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

S-15261 is an orally active and potent anti-hyperglycemic agent. S-15261 reduces hepatic glucose production through direct and insulin-sensitizing effects. S-15261 can be used for the research of insulin resistance syndrome .
loading...
    loading...